Watts AB - Search Results

1

Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.

Liu S, Watts AB, Du J, Bui A, Hengsawas S, Peters JI, Williams RO 3rd. Liu S, et al. Among authors: watts ab. Eur J Pharm Biopharm. 2015 Oct;96:132-42. doi: 10.1016/j.ejpb.2015.07.017. Epub 2015 Jul 26. Eur J Pharm Biopharm. 2015. PMID: 26220015

2

Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a lung transplanted rodent model.

Watts AB, Cline AM, Saad AR, Johnson SB, Peters JI, Williams RO 3rd. Watts AB, et al. Int J Pharm. 2010 Jan 15;384(1-2):46-52. doi: 10.1016/j.ijpharm.2009.09.040. Epub 2009 Sep 25. Int J Pharm. 2010. PMID: 19782740

3

Preclinical evaluation of tacrolimus colloidal dispersion for inhalation.

Watts AB, Peters JI, Talbert RL, O'Donnell KP, Coalson JJ, Williams RO 3rd. Watts AB, et al. Eur J Pharm Biopharm. 2011 Feb;77(2):207-15. doi: 10.1016/j.ejpb.2010.11.013. Epub 2010 Dec 3. Eur J Pharm Biopharm. 2011. PMID: 21130874

4

The impact of pulmonary diseases on the fate of inhaled medicines--a review.

Wang YB, Watts AB, Peters JI, Williams RO 3rd. Wang YB, et al. Among authors: watts ab. Int J Pharm. 2014 Jan 30;461(1-2):112-28. doi: 10.1016/j.ijpharm.2013.11.042. Epub 2013 Nov 27. Int J Pharm. 2014. PMID: 24291124 Review.

5

Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.

Carvalho SR, Watts AB, Peters JI, Liu S, Hengsawas S, Escotet-Espinoza MS, Williams RO 3rd. Carvalho SR, et al. Among authors: watts ab. Eur J Pharm Biopharm. 2014 Sep;88(1):136-47. doi: 10.1016/j.ejpb.2014.05.008. Epub 2014 May 22. Eur J Pharm Biopharm. 2014. PMID: 24859653

6

Delivery Technologies for Orally Inhaled Products: an Update.

Moon C, Smyth HDC, Watts AB, Williams RO 3rd. Moon C, et al. Among authors: watts ab. AAPS PharmSciTech. 2019 Feb 19;20(3):117. doi: 10.1208/s12249-019-1314-2. AAPS PharmSciTech. 2019. PMID: 30783904 Review.

7

Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation.

Moon C, Watts AB, Lu X, Su Y, Williams RO 3rd. Moon C, et al. Among authors: watts ab. Mol Pharm. 2019 May 6;16(5):1799-1812. doi: 10.1021/acs.molpharmaceut.8b00907. Epub 2019 Apr 10. Mol Pharm. 2019. PMID: 30925839

8

Current therapies and technological advances in aqueous aerosol drug delivery.

Watts AB, McConville JT, Williams RO 3rd. Watts AB, et al. Drug Dev Ind Pharm. 2008 Sep;34(9):913-22. doi: 10.1080/03639040802144211. Drug Dev Ind Pharm. 2008. PMID: 18663654 Review.

9

Recent developments in drug delivery to prolong allograft survival in lung transplant patients.

Watts AB, Williams RO 3rd, Peters JI. Watts AB, et al. Drug Dev Ind Pharm. 2009 Mar;35(3):259-71. doi: 10.1080/03639040802282904. Drug Dev Ind Pharm. 2009. PMID: 18798087 Review.

10

Respirable low-density microparticles formed in situ from aerosolized brittle matrices.

Watts AB, Wang YB, Johnston KP, Williams RO 3rd. Watts AB, et al. Pharm Res. 2013 Mar;30(3):813-25. doi: 10.1007/s11095-012-0922-2. Epub 2012 Nov 15. Pharm Res. 2013. PMID: 23229856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters